Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AgelessRx vs Hers

By GLP-1 ScorecardUpdated

AgelessRx
Site position #17

Higher grade

Hers
Site position #359

Lower grade

Score comparison

AgelessRx has the higher recorded score — 84.3/100 to 60.7/100.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueAgelessRx +36
90
54
Dose & formulationAgelessRx +3
80
77
Clinical oversightAgelessRx +28
83
55
Labs & monitoringAgelessRx +30
82
52
FulfillmentAgelessRx +3
84
81
Contract termsAgelessRx +44
85
41
AgelessRx · top barHers · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAgelessRxHers
WeighScore84.3/10060.7/100
GradeBC
Site position#17#359
SemaglutideNot verified (current medication-specific quote required)From $149/mo (Wegovy pill; plus required care: $39 first month, then $149/mo)
TirzepatideMicrodose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote requiredFrom $299/mo (Zepbound vial or KwikPen; plus required care: $39 first month, then $149/mo)
CoverageAdvertises US service; confirm treatment-specific state availabilityNot available in every state; confirm eligibility
Brand-name accessYesYes
Oral / sublingualYesYes
AgelessRx

Site position #17 · B

Strengths

  • Conventional and lower-dose GLP-1 programs advertised
  • Wegovy pens and oral-tablet consultations advertised
  • Continuing messaging and check-ins advertised

What to consider

  • Conventional medication-specific monthly quotes not verified
  • Microdose introduction renews as a two-month charge
  • Branded medication has a separate pharmacy bill
  • Treatment-specific state eligibility and assigned dispenser need confirmation
Hers

Site position #359 · C

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.

Strengths

  • Branded Wegovy pill and pen, plus Zepbound vial or KwikPen options listed
  • Ongoing provider messaging and monthly care-team follow-ups described
  • Published membership and medication charges can be compared separately

What to consider

  • Required care membership is $39 first month, then $149 monthly, extra to medication
  • Membership and medication cancellation are separate; shipped prepaid supply may keep membership charges payable
  • Availability and medication prices depend on state, product, dose and plan
  • FDA issued Hims & Hers Health, Inc. dba Hers a warning letter in September 2025 concerning compounded-semaglutide promotion; this is distinct from current branded-product approval

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard